Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Cash from Financing Activities: 2018-2024

Historic Cash from Financing Activities for Milestone Pharmaceuticals (MIST) over the last 7 years, with Dec 2024 value amounting to $32.1 million.

  • Milestone Pharmaceuticals' Cash from Financing Activities rose 146.74% to $227,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $3.1 million, marking a year-over-year decrease of 38.91%. This contributed to the annual value of $32.1 million for FY2024, which is 32.79% down from last year.
  • Milestone Pharmaceuticals' Cash from Financing Activities amounted to $32.1 million in FY2024, which was down 32.79% from $47.8 million recorded in FY2023.
  • In the past 5 years, Milestone Pharmaceuticals' Cash from Financing Activities registered a high of $73.2 million during FY2020, and its lowest value of $3.1 million during FY2022.
  • Its 3-year average for Cash from Financing Activities is $27.7 million, with a median of $32.1 million in 2024.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first crashed by 93.10% in 2021, then surged by 1,447.67% in 2023.
  • Milestone Pharmaceuticals' Cash from Financing Activities (Yearly) stood at $73.2 million in 2020, then slumped by 93.10% to $5.1 million in 2021, then tumbled by 38.91% to $3.1 million in 2022, then soared by 1,447.67% to $47.8 million in 2023, then tumbled by 32.79% to $32.1 million in 2024.